CDC data reveals declining COVID hospitalizations.

COVID-19 Hospitalizations Continue to Drop, CDC Data Shows

Data released by the U.S. Centers for Disease Control and​ Prevention (CDC) ⁢reveals that hospitalizations for COVID-19 have been​ steadily​ decreasing, following a slight increase in cases over the summer.

In the week ending on⁤ October 14,‍ hospitalizations dropped by 5 percent. ‍Emergency department visits also decreased by 11.9 percent, and ⁣reported case numbers saw a 0.7 percent decline. However, there was a 4.2 percent increase in deaths, ‍which is expected as deaths typically lag ⁣behind case and‍ hospitalization⁣ numbers.

The previous‌ week, ending on October 7, saw‌ an 8.2 percent decrease⁣ in‌ hospitalizations, a 17.7 percent decrease in emergency visits, and a 0.8⁣ percent‍ decrease in reported⁤ cases. Deaths were down by 3.8 percent, ​according to‍ the data.

Related ‌Stories

COVID-19 mRNA Vaccines⁣ Reduce‍ a Major Beneficial Bacteria, Gut Biodiversity: Research

10/26/2023

Regulator ⁢Didn’t Tell Public About ​Post COVID-19 Vaccination Myocarditis for Four Months

10/26/2023

Despite​ the‍ consecutive drop in hospitalizations, ‍the CDC issued a report earlier this ‍month emphasizing that ‌the virus remains a‌ “public health ⁤threat” for older Americans, highlighting the importance of getting the updated COVID-19 vaccine. ⁣The ⁤Food and Drug Administration ⁣(FDA) and CDC have‌ approved the ‍updated shots⁤ from Pfizer, Moderna, and ⁣Novavax.‍

Few ​Americans ⁣Taking ⁣Updated​ Shots

At the same ​time,⁣ the ‌CDC⁢ warned of a potential “moderate COVID-19 wave” during the ⁣upcoming ​winter months, projecting that this year’s peak will match the hospitalization figures from ‍last winter. The agency attributed the ​possibility of ⁤an earlier peak to reduced⁤ summer​ activity‌ compared to ​previous years, ⁢as ​stated in September.

The CDC stated, “This increase could result from the emergence‍ of a new COVID-19 variant with an increased ability to evade the body’s prior immunity, or from a severe influenza season combined with COVID-19 and​ RSV ⁤waves that are similar to last year, ‍or, as we saw last year,⁣ an increase in RSV infections. A key factor is⁤ the timing of the⁤ peak number of‍ hospitalizations associated with each disease and whether those peaks coincide.”

According to the ‌Department of‌ Health and Human Services ‌(HHS), only about 3 percent of eligible ⁤Americans ​have received the updated COVID-19 booster⁣ shot, ‌nearly two months ⁢after ‌its ⁣rollout. The‌ data shows that approximately 10 million⁤ people have taken ⁣the booster shot, an increase from 7 million the previous⁤ week.

“The administration remains committed ‌to pulling ⁤every lever at its disposal during the fall respiratory vaccination campaign, encouraging the American public to‌ stay up to date on their vaccines ⁣to keep themselves and their loved ones ⁢safe,” said an HHS spokesperson.⁤ “As a result of these efforts, around 10 million Americans have been vaccinated since the updated vaccines were authorized and recommended ‌last month.”

The decline in vaccine demand has ⁢led pharmaceutical giant Pfizer to revise its​ revenue guidance for the year, with⁢ a projected $9 billion decrease due to weakened demand.‌ Sales of Pfizer’s mRNA vaccine are expected to‍ be about $2 billion lower ⁣than previously anticipated.

Moderna,‍ on the other hand,⁤ reiterated that ‌its ⁤COVID-19⁣ vaccine sales will range between $6 billion and⁤ $8 billion. However, it is still too early to predict the U.S. vaccination rate,⁣ as ‍Moderna’s stock ⁣has plummeted by $7‌ billion ‍in just ⁢a week ⁢and has dropped 83⁣ percent since its peak⁣ in August 2021.

Analysts have expressed concerns about the declining ‌vaccine sales for these pharmaceutical companies.

“COVID-19 vaccine revenue concerns should be at an all-time high right now,” ⁢said Hartaj Singh, an analyst at Oppenheimer. “A good third-quarter report should alleviate some of these fears.‌ And positive guidance for ​potential revenues in 2024 could restore confidence in the stock.”

Meanwhile, several U.S. hospitals have⁤ recently lifted their COVID-19‌ mask mandates ​after reinstating them ‍a few weeks ago. Some⁣ hospitals had reintroduced mandates over the summer, although ⁢they ⁢were not mandatory for patients or visitors, only for staff⁤ members.

Hackensack⁤ Meridian Health, ⁢the largest hospital group in New Jersey, has lifted its mask⁤ mandate for ⁤all hospitals⁣ except for ⁢Bayshore⁤ Medical Center, Old Bridge Medical Center, and Southern Ocean Medical Center, according to local media reports.

, could put a strain on healthcare⁣ systems.⁢ To address this, ‌the U.S. Health Secretary Xavier Becerra stated that efforts are being made to ensure that anyone who wants a booster ⁣shot can⁢ easily access one. ⁢In light of ​this, here are three PAA related‌ questions:

O‌ ensuring that anyone who wants a booster shot can get one, and we are working to⁢ make the⁣ process as⁤ easy and convenient as possible,” said U.S. Health Secretary Xavier Becerra. “Boosters are an important tool in our fight against COVID-19, particularly as we navigate the ​potential challenges⁤ of the upcoming winter season.”

The CDC has been actively encouraging eligible individuals to get⁢ the updated COVID-19 booster shot, which ⁤is recommended for those who are at least six months⁣ past their initial vaccination. The booster shot‍ is intended to⁤ strengthen the body’s immune response⁤ and provide further ⁤protection against COVID-19 and its ⁣variants.

Despite the CDC’s efforts, recent data shows that only a‍ small percentage of eligible Americans⁣ have received the booster shot. This ‌could potentially hinder the country’s ability to control the spread ​of COVID-19 and prevent ⁤a surge in‍ hospitalizations during the winter ⁢months.

Health‍ officials have warned that the combination of COVID-19 and other respiratory viruses, such as⁤ influenza